Feed BLCO
BL

Bausch + Lomb

BLCO · NYSE

$17.10 +0.94% (+$0.16)
1M -5.16%
Market Cap $6.05B
P/E Ratio -
Div. Yield -
ROE 2.67%

Bulios Fair Price

$10.21

40.3% downside

Trenutna cena

$17.1

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica BLCO trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Analiza

AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.

Piotroski F-Score Moderate
4/9
Valuation
53 /100
Fair
EV/EBITDA 14.56x
P/S 1.14x
P/FCF 43.14x
Growth
56 /100
Stable
Rev. growth 10.62%
Book val. growth 2.85%
EPS growth N/A
Profitability
36 /100
Moderate
Gross margin 57.23%
Net margin 3.21%
FCF margin 2.64%
Quality
22 /100
Poor
ROIC 7.93%
ROE 2.67%
Asset turnover 0.38x
Debt
32 /100
High
Debt/Equity 0.80x
Current ratio 1.55x
Net debt/EBITDA 6.40x
Stability
53 /100
Moderate
Beta 0.56x
Rev. volatility 4.58%
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o BLCO
Online

O podjetju

Bausch + Lomb Corporation is a Canadian global company specializing in the development, manufacturing, and marketing of healthcare products, particularly in the field of ophthalmology and eye care. The company offers a wide range of products, including contact lenses, eye drops, surgical instruments for eye surgeries, and medications for treating various eye conditions. Bausch + Lomb also focuses on the development of advanced eye technologies and providing comprehensive vision care for patients worldwide. The company is known for its long-standing tradition and expertise in eye medicine.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Brenton L. Saunders

Employees

13,000

Headquarters

Vaughan

Prihajajoči dogodki

04 NOV.

Earnings

Upcoming earnings report

31d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.